GDF15 and chronic kidney disease: Transthyretin, GDF15, FGF21, and alanine:serine ratio showed dependence on the cystatin C–based and creatinine-based eGFR (data not shown) and thus their potential utility in clinical trials may not extend to patients with, or at high risk of, advanced CKD.